Literature DB >> 3873983

Delays in the primary vaccination of children.

R Allard, M Guy, L Durand, E Hudon, Y Robert.   

Abstract

The results of a population-based survey of 170 children's vaccination records were used to calculate the cumulative distributions of the ages (in months) at which each dose of vaccine had been received. Considerable delays in the administration of measles-mumps-rubella (MMR) vaccine and of the fourth dose of diphtheria-pertussis-tetanus vaccine were observed, particularly in children vaccinated by private physicians rather than at public health clinics. The delay before MMR vaccination causes concern because of the frequency of measles in children aged 1 to 2 years, particularly those attending day-care centres, and the fragility of the herd immunity against this disease. Physicians should follow up patients who have missed appointments for MMR vaccination if a voluntary measles control program is to succeed.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3873983      PMCID: PMC1346020     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  5 in total

Review 1.  Measles and rubella in the United States.

Authors:  H W Hethcote
Journal:  Am J Epidemiol       Date:  1983-01       Impact factor: 4.897

2.  Policy for measles elimination in Canada and program implications.

Authors:  F M White
Journal:  Rev Infect Dis       Date:  1983 May-Jun

3.  Elimination of indigenous measles from the United States.

Authors:  A R Hinman; C D Kirby; D L Eddins; W A Orenstein; R H Bernier; P M Turner; K J Bart
Journal:  Rev Infect Dis       Date:  1983 May-Jun

4.  Effect of timing of measles vaccination on compliance with immunizations during the second year of life.

Authors:  J L Sherrod; R Kane; J D Cherry; J Fricker; K Maples
Journal:  J Pediatr       Date:  1983-02       Impact factor: 4.406

5.  The organization and evaluation of a computer-assisted, centralized immunization registry.

Authors:  H Loeser; I Zvagulis; L Hercz; I B Pless
Journal:  Am J Public Health       Date:  1983-11       Impact factor: 9.308

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.